Multi‐modal prehabilitation: addressing the why, when, what, how, who and where next?
C Scheede‐Bergdahl, EM Minnella, F Carli - Anaesthesia, 2019 - Wiley Online Library
Just as there is growing interest in enhancing recovery after surgery, prehabilitation is
becoming a recognised means of preparing the patient physically for their operation and/or …
becoming a recognised means of preparing the patient physically for their operation and/or …
[HTML][HTML] Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions
S Chakrabarti, CY Peterson, D Sriram… - World journal of …, 2020 - ncbi.nlm.nih.gov
Colon cancer continues to be one of the leading causes of mortality and morbidity
throughout the world despite the availability of reliable screening tools and effective …
throughout the world despite the availability of reliable screening tools and effective …
[HTML][HTML] Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Colorectal cancer (CRC) is the third most common tumour in men and the second in women,
accounting for 10% of all tumour types worldwide. Incidence is 25% higher in males and …
accounting for 10% of all tumour types worldwide. Incidence is 25% higher in males and …
[HTML][HTML] Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO …
RR Bahadoer, GAP Hospers, CAM Marijnen… - European Journal of …, 2023 - Elsevier
Introduction Although optimising rectal cancer treatment has reduced local recurrence rates,
many patients develop distant metastases (DM). The current study investigated whether a …
many patients develop distant metastases (DM). The current study investigated whether a …
Refining adjuvant therapy for non-metastatic colon cancer, new standards and perspectives
Colon cancer is the third most frequent cancer in males and the second in females.
Approximately 75% are diagnosed at a localized stage. Recurrence occurs in 30% of …
Approximately 75% are diagnosed at a localized stage. Recurrence occurs in 30% of …
Adjuvant chemotherapy for stage II colon cancer
SE Rebuzzi, G Pesola, V Martelli, AF Sobrero - Cancers, 2020 - mdpi.com
Simple Summary Stage II colon cancer is defined as an early stage of the tumor disease,
without the involvement of lymph nodes or distant organs. In this group of patients, surgery …
without the involvement of lymph nodes or distant organs. In this group of patients, surgery …
Timing of adjuvant chemotherapy and survival in colorectal, gastric, and pancreatic cancer. A systematic review and meta-analysis
(1) Background: The optimal timing of adjuvant chemotherapy (CT) in gastrointestinal
malignancies is still a matter of debate. For colorectal cancer, it is recommended to start post …
malignancies is still a matter of debate. For colorectal cancer, it is recommended to start post …
Long-term oncological outcomes after colorectal anastomotic leakage: a retrospective Dutch population-based study
MNN Arron, NG Greijdanus, S Bastiaans… - Annals of …, 2022 - journals.lww.com
Objective: The aim was to evaluate the impact of anastomotic leak (AL) after colon cancer
(CC) and rectal cancer (RC) surgery on 5-year relative survival, disease-free survival (DFS) …
(CC) and rectal cancer (RC) surgery on 5-year relative survival, disease-free survival (DFS) …
Textbook oncologic outcome is associated with increased overall survival after esophagectomy
Background Assessment of quality in oncologic operations traditionally involves use of
discrete metrics reported individually. Such metrics have limited value to payers and patients …
discrete metrics reported individually. Such metrics have limited value to payers and patients …